Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7701–7750 of 18431
On October 31, 2023, each of (i) Mr. Jasper Bos and (ii) Mr. Cyril Lesser resigned as Chief Executive Officer and Chief Financial Officer, respectively, of the Company, effective on October 31, 2023 upon the completion of the Business Combination.
Mr. Robitaille will continue to serve as an executive officer of the Company until November 17, 2023;
On October 29, 2023, Adrian Adams gave notice of his resignation from his position as Chairman of the Board and as President and Chief Executive Officer of Impel Pharmaceuticals Inc. (the “ Company ”) effective November 4, 2023.
The Board of Directors of the Company intends to appoint Leonard S. Paolillo as Interim President and Chief Executive Officer effective upon Mr. Adams’s resignation.
the Board has appointed Maria Hollandsworth as interim Chief Executive Officer and President of the Company (“ Interim CEO ”), effective as of November 4, 2023.
On November 2, 2023, El Pollo Loco Holdings, Inc. (the “ Company ”) announced that Laurance Roberts, the Company’s Chief Executive Officer and President, is leaving his position as Chief Executive Officer and President and as a member of the Board of Directors of the Company (the “ Board ”), effective as of the close of business on November 3, 2023
On November 2, 2023, Silk Road Medical, Inc. (the “Company”) announced the appointment of Charles (Chas) McKhann as Chief Executive Officer (“CEO”) and a director of the Company, effective immediately.
Mr. McKhann will succeed Erica J. Rogers, who is retiring, effective November 2, 2023, and has served on the Company’s Board of Directors and as President and Chief Executive Officer for over 11 years.
The Executive Committee of the Board of Directors of the Company (the “Committee”) has appointed David Wheeler, the Company’s current President, as Interim CEO.
Steven B. Treadwell provided notice of his resignation as Chief Executive Officer (“CEO”) of Silver Star Properties REIT, Inc. (the “Company”), effective October 27, 2023.
Mr. Sauve is the Chief Executive Officer of the Company post Business Combination.
Mr. Jensen also resigned as Chief Executive Officer of the Company
The Company has named Phillip Sawarynski as Mr. Barnes's successor in that role.
appointed Bradford J. Helgeson as Executive Vice President and Chief Financial Officer of the Company, effective November 6, 2023.
Izzy Martins, currently serving as EVP Americas of the Company, will assume the role of EVP & Chief Financial Officer of the Company, effective January 1, 2024.
Leagh E. Turner, co-Chief Executive Officer of Ceridian HCM Holding Inc. (the “Company”) notified the Company of her intent to resign as co-Chief Executive Officer and as a member of the Board of Directors of the Company effective on November 10, 2023.
David D. Ossip, Chair of the Board and co-Chief Executive Officer of the Company, will become sole Chief Executive Officer of the Company.
On November 1, 2023, Eldron C. Blackwell was appointed as the Company's Chief Financial Officer, Senior Vice President and Treasurer, effective January 1, 2024.
On November 1, 2023, David J. Bryant, Chief Financial Officer, Senior Vice President and Treasurer, informed the Company of his intention to retire effective December 31, 2023.
On November 1, 2023, the Board appointed Craig R. Jalbert, age 61, as the Company’s President, Treasurer, Corporate Secretary, effective as of 12:00 a.m. on November 2, 2023, and sole member of the Board, effective immediately.
On November 1, 2023, in connection with the Assignment (as defined below), William R. Hinshaw, Jr. and Paul Fehlner were each notified by the Company of termination of their positions as President and Chief Executive Officer and Senior Vice President, Chief Legal Officer and Corporate Secretary, respectively, effective as of 11:59 p.m. on November 1, 2023.
On October 30 , 2023, the Board of Directors (the “Board” ) of Ocuphire Pharma, Inc. (the “Company” ) appointed Dr. George Magrath, age 39, as the Company’s Chief Executive Officer, effective as of November 1, 2023.
On October 30, 2023, the Board of Directors (the “Board”) of Spero Therapeutics, Inc. (the “Company”) appointed Esther Rajavelu as the Company’s Chief Financial Officer and Chief Business Officer.
Reginald Seeto, MBBS, the President and Chief Executive Officer of CareDx, Inc. (the “Company”), resigned from the Company.
appointed Jamie Miller as the Company's Executive Vice President, Chief Financial Officer, effective November 6, 2023.
the Board appointed Mr. Jeremy Frommer as the Chief Financial Officer of the Company, effective October 16, 2023.
the Board determined it was in the best interest of the Company to accept Mr. Pickens' resignation and to continue his engagement with the Company as a finance and accounting consultant.
On November 1, 2023, the Company announced that Elizabeth Howe, 53, will join the Company and become Executive Vice President and Chief Financial Officer on November 8, 2023.
On October 30, 2023, Arthur Chadwick, Executive Vice President and Chief Financial Officer of the Company, notified us of his decision to retire and resign from all of his officer positions with the Company and all of its subsidiaries, effective November 7, 2023
As previously reported, on October 17, 2023, the Board approved the mutual termination of Amber Mason as Chief Executive Officer of the Company, effectively immediately.
This Current Report on Form 8-K/A amends the Original 8-K to include information about Benson’s compensatory arrangements in connection with his appointment as Interim Chief Executive Officer.
Mr. Sispoidis resigned from all director, officer, and any other positions and/or roles he had with the Company and each of its wholly-owned subsidiaries, Carbon-Ion and Oxcion, including Chief Executive Officer and Secretary, effective as of November 1, 2023.
the Company announced the appointment of Donavon P. Ternes as President and Chief Executive Officer of the both the Company and the Bank effective on January 1, 2024.
Concurrent with the Bankruptcy Filing, on October 30, 2023, Yishai Zohar, President, Chief Executive Officer, Interim Principal Financial Officer and Principal Accounting Officer, Treasurer, Chief Compliance Officer and Corporate Secretary, and David Pass, Chief Operating Officer and Chief Commercial Officer, tendered their resignations, effective October 30, 2023.
Mr. Valentine will succeed Lawrence (“Chip”) Molloy, who previously announced his intention to retire as the Company’s Chief Financial Officer on or about December 31, 2023.
On October 31, 2023, Sprouts Farmers Market, Inc. (the “Company”) appointed Curtis Valentine as Chief Financial Officer, effective January 1, 2024.
On October 31, 2023, Marchex, Inc. (“Marchex” or the “Company”) announced that Holly A. Aglio (“Aglio”) joined Marchex as its Chief Financial Officer effective October 30, 2023
appointment of Christopher Boerner, Ph.D. as Chief Executive Officer by the Board, effective November 1, 2023
received notice from Robert Ho of his intention to resign as the Company’s Chief Financial Officer, effective November 10, 2023.
On October 31, 2023, Sensata Technologies Holding plc (“the Company”) announced that Paul Vasington, Executive Vice President and Chief Financial Officer, has decided to retire from the Company, effective immediately following the filing of the Quarterly Report on Form 10-Q for the third quarter 2023 (the "Form 10-Q Filing") in early November.
On October 31, 2023, the Company announced that Brian K. Roberts has been named as the Company's new Chief Financial Officer (“CFO”), pursuant to Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended, effective immediately following the Form 10-Q Filing (the "Effective Date").
On October 27th, 2023, Tom Valenzuela, the Company’s Interim Chief Executive Officer and Chairman of the Board, submitted his resignation as Chief Executive Officer effective as of October 27, 2023.
On October 28, 2023, the Company’s board of directors appointed John Gorst as interim Chief Executive Officer of the company, effective as of October 28, 2023.
Effective October 31, 2023, the Board appointed Ms. Elsner as the Company’s Chief Executive Officer.
the Board appointed Seth Kaufman as the Company's President and CEO, effective on or prior to October 30, 2023.
In connection with Mr. Kaufman's appointment, Jon Moramarco will no longer serve as the Interim Chief Executive Officer of the Company. Mr. Moramarco will remain on the Company’s Board.
Guy Gecht will no longer serve as Interim Chief Executive Officer of Logitech, also effective December 1, 2023.
Johanna W. (Hanneke) Faber will join Logitech as Chief Executive Officer, effective December 1, 2023.
On October 30, 2023, the Company announced the hiring of Gabe Ellwein, 45, and his appointment as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) of the Company, succeeding John A. Krier.
On October 30, 2023, the Company announced the hiring of Gabe Ellwein, 45, and his appointment as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) of the Company, succeeding John A. Krier.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.